Hepatitis B Virus Testing Market: By Test Type (Hepatitis B Surface Antigen Test (HBsAg), Anti-hepatitis B Surface Antibody Test, Hepatitis B Core Antigen Test (HBcAb), Anti-hepatitis B Core Antibody Test, HBV DNA Test and Others), By Techniques (PCR, Radioimmunoassay (RIA), Enzyme-linked immunosorbent assay (ELISA) and Others), By End User (Hospitals, Diagnostic Centers and Clinics) and Geography     

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Hepatitis B Virus Testing Market size is valued at USD 849.07 million in 2021 and is expected to reach USD 1319.44 million by 2028, at a CAGR of 6.5% during the forecast period 2022-2028. Increase in liver cancer cases, growing aging population, healthcare spending and urbanization. leading to better monitoring and screening procedures. In addition, government initiatives in growing awareness in public, increase in R&D spending by companies and growing demand for bio marker tests due to its accuracy expected to boost the hepatitis B virus testing market during the forecast period. However, factors such as lack of awareness in developing countries, stringent regulatory rules, rigid competition and high cost of testing are expected to hamper the hepatitis B virus testing market over the forecast period. Hepatitis B is a liver disease caused by the Hepatitis B virus (HBV). Hepatitis B viral infection ranges can form mild infection which last few weeks and a chronic infection that may lead to liver disorders and even death. Hepatitis B is one of the global health problem. Hepatitis B can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. The virus is transmitted through contact with the blood or other body fluids of an infected person. According to World Health Organization, 257 Mn people are living with hepatitis B virus infection worldwide and in 2015, 887 000 hepatitis B resulted deaths. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Hepatitis B Virus Testing Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Global Hepatitis B Virus Testing Market Summary

Study Period

2023-29

Base Year

2022

CAGR

6.5%

Largest Market

North-America

Fastest Growing Market

Europe
Hepatitis B Virus Testing Market Dynamics

The rise in global hepatitis B prevalence might be attributed to the growth of the hepatitis B diagnostic testing market. According to the World Health Organization, it affects more than 300 million people worldwide. Furthermore, it is well-known that its frequency is particularly high in the Western Pacific and African regions. Perinatal transmission and horizontal transfer by infected blood are both prominent causes of infection in endemic areas. Increased public awareness, as well as increased government and non-profit initiatives, all contribute to the market's growth. As people become more aware of the disease, it gets diagnosed earlier. Hepatitis B diagnostic tests are in high demand as a result of this. The global hepatitis B diagnostic testing market is expected to be hampered by a lack of common recommendations for hepatitis B diagnosis.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Hepatitis B Virus Testing Market Segmentation

By Test Type
  • Hepatitis B Surface Antigen Test (HBsAg)
  • Anti-hepatitis B Surface Antibody Test
  • Hepatitis B Core Antigen Test (HBcAb)
  • Anti-hepatitis B Core Antibody Test
  • HBV DNA Test
  • Others
By Techniques
  • PCR
  • Radioimmunoassay (RIA)
  • Enzyme-linked immunosorbent assay (ELISA)
  • Others
By End User
  • Hospitals
  • Diagnostic Centers
  • Clinics

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Executive summary
  2. Global Hepatitis B Virus Testing Market Introduction
    • Global Hepatitis B Virus Testing Market– Taxonomy
    • Global Hepatitis B Virus Testing Market–Definitions
      • Test Type
      • Technique
  1. Global Hepatitis B Virus Testing Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Hepatitis B Virus Testing Market Dynamics – Factors Impact Analysis
    • Global Hepatitis B Virus Testing Market– Recent Market Introductions
  2. Global Hepatitis B Virus Testing Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Oppurtunity Analysis
  3. Global Hepatitis B Virus Testing Market Forecast, By Test Type, 2013 - 2017 and Forecast, 2018 - 2024
    • Hepatitis B Surface Antigen Test (HBsAg)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-hepatitis B Surface Antibody Test
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hepatitis B Core Antigen Test (HBcAb)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-hepatitis B Core Antibody Test
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • HBV DNA Test
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hepatitis B Virus Testing Market Forecast, By Technique, 2013 - 2017 and Forecast, 2018 - 2024
    • PCR
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Radioimmunoassay (RIA)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Enzyme-linked immunosorbent assay (ELISA)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hepatitis B Virus Testing Market Forecast, By End User, 2013 - 2017 and Forecast, 2018 - 2024
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hepatitis B Virus Testing Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Hepatitis B Virus Testing Market- Opportunity Analysis Index - By Technique, By Test Type, By End User, and Region, 2018 – 2024
  2. North America Hepatitis B Virus Testing Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Technique Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • Radioimmunoassay (RIA)
      • Enzyme-linked immunosorbent assay (ELISA)
      • Others
    • Test Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hepatitis B Surface Antigen Test (HBsAg)
      • Anti-hepatitis B Surface Antibody Test
      • Hepatitis B Core Antigen Test (HBcAb)
      • Anti-hepatitis B Core Antibody Test
      • HBV DNA Test
      • Others
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Clinics
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Hepatitis B Virus Testing Market- Opportunity Analysis Index - By Technique, By Test Type, By End User, and Country, 2018 – 2024
    • North America Hepatitis B Virus Testing Market Dynamics – Trends
  3. Europe Hepatitis B Virus Testing Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Technique Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • Radioimmunoassay (RIA)
      • Enzyme-linked immunosorbent assay (ELISA)
      • Others
    • Test Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hepatitis B Surface Antigen Test (HBsAg)
      • Anti-hepatitis B Surface Antibody Test
      • Hepatitis B Core Antigen Test (HBcAb)
      • Anti-hepatitis B Core Antibody Test
      • HBV DNA Test
      • Others
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Clinics
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Hepatitis B Virus Testing Market- Opportunity Analysis Index - By Technique, By Test Type, By End User, and Country, 2018 – 2024
    • Europe Hepatitis B Virus Testing Market Dynamics – Trends
  4. Asia-Pacific Hepatitis B Virus Testing Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Technique Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • Radioimmunoassay (RIA)
      • Enzyme-linked immunosorbent assay (ELISA)
      • Others
    • Test Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hepatitis B Surface Antigen Test (HBsAg)
      • Anti-hepatitis B Surface Antibody Test
      • Hepatitis B Core Antigen Test (HBcAb)
      • Anti-hepatitis B Core Antibody Test
      • HBV DNA Test
      • Others
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Clinics
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),
  5. Y-o-Y Growth (%), and Market Share (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Asia-Pacific Hepatitis B Virus Testing Market- Opportunity Analysis Index - By Technique, By Test Type, By End User, and Country, 2018 – 2024
  • Asia-Pacific Hepatitis B Virus Testing Market Dynamics – Trends
  1. Latin America Hepatitis B Virus Testing Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Technique Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • Radioimmunoassay (RIA)
      • Enzyme-linked immunosorbent assay (ELISA)
      • Others
    • Test Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hepatitis B Surface Antigen Test (HBsAg)
      • Anti-hepatitis B Surface Antibody Test
      • Hepatitis B Core Antigen Test (HBcAb)
      • Anti-hepatitis B Core Antibody Test
      • HBV DNA Test
      • Others
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Clinics
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Hepatitis B Virus Testing Market- Opportunity Analysis Index - By Technique, By Test Type, By End User, and Country, 2018 – 2024
    • Latin America Hepatitis B Virus Testing Market Dynamics – Trends
  2. Middle East & Africa Hepatitis B Virus Testing Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Technique Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • Radioimmunoassay (RIA)
      • Enzyme-linked immunosorbent assay (ELISA)
      • Others
    • Test Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hepatitis B Surface Antigen Test (HBsAg)
      • Anti-hepatitis B Surface Antibody Test
      • Hepatitis B Core Antigen Test (HBcAb)
      • Anti-hepatitis B Core Antibody Test
      • HBV DNA Test
      • Others
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Clinics
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Hepatitis B Virus Testing Market- Opportunity Analysis Index - By Technique, By Test Type, By End User, and Country, 2018 – 2024
    • MEA Hepatitis B Virus Testing Market Dynamics – Trends
  3. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Onsite Lab Holding AG (MedMira Inc.) (Switzerland)
      • Hoffmann-La Roche (Switzerland)
      • Abbott Laboratories (USA)
      • Siemens AG (Siemens Healthcare GmbH) (Germany)
      • Thermo Fisher Scientific (France)
      • Innovita biological technology Co. Ltd. (China)
      • General Biologicals Corporation (Taiwan)
      • Nantong Diagnos Biotechnology Co. Ltd. (China)
      • BioGenex (U.S.)
      • Abnova Corporation (U.S.)
  4. Research Methodology
  5. Key Assumptions and Acronyms
  • Onsite Lab Holding AG (MedMira Inc.) (Switzerland)
  • F. Hoffmann-La Roche (Switzerland)
  • Abbott Laboratories (U.S.)
  • Siemens AG (Siemens Healthcare GmbH) (Germany)
  • Fisher Bioblock Bolding (Thermo Fisher Scientific) (France)
  • Innovita biological technology Co. Ltd. (China)
  • General Biologicals Corporation (Taiwan)
  • Nantong Diagnos Biotechnology Co. Ltd. (China)
  • Blue Cross Bio-Medical  Co. Ltd. (China)
  • BioGenex (U.S.)
  • Abnova Corporation (U.S.)